Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 INTELLECTUAL PROPERTY Our intellectual property, including patent applications and trade secrets, is based on novel methods for the manufacturing, formulating, dosing, and administering of psychedelic compounds resulting in material benefits across multiple indications Tryp most recently filed a provisional patent in March 2021 ԺUS 63/161,070Ի describing innovative techniques resulting in a potential reduction in the time spent by patients in the dissociative state We have retained Morrison & Foerster to prosecute our patent applications 25